Overlooked Stocks: APRN, ALV, PTGX
b'Blue Apron (APRN) reported a planned $78M equity capital raise on September 15th. The stock is up 40% in 2021. The next stock that George Tsilis discusses is Autoliv (ALV), an automotive safety supplier. Barclays recently upgraded the stock to overweight with a $105 price target. Finally, he discusses Protagonist Therapeutics (PTGX), a clinical stage biopharmaceutical company. The stock was a mover today and was upgraded at Northland Capital to outperform with a $40 price target.'